MR cracks ‘age-doping” in international youth soccer
MRI has been adopted by the International Federation of Association Football as a definitive measure to ensure fair play.
MRI has been adopted by the International Federation of Association Football as a definitive measure to ensure fair play.
FIFA, the governing body for international soccer competition, launched a program of random MRI wrist screening this month to verify the age of players competing in the U-17 (under 17) World Cup, which is being hosted by Nigeria. The issue of fielding overage players has been around for some time because the global competition draws talent from many parts of the world where age cannot be clearly determined. With this method, FIFA will guarantee that all players are really biologically under 17, according to FIFA's chief medical officer, Prof. Jiri Dvorak.
“MRI can determine age below or over 17 with a certainty of 99%,” he said.
FIFA-sanctioned competitions had used x-rays for this purpose in the past. But several member associations raised concerns about the use of ionizing radiation. This led the organization to look to MRI instead, Dvorak said.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
